-
FDA approves GlaxoSmithKline niraparib for treatment of terminal ovarian cancer
Time of Update: 2020-06-07
Today, the U.S FDA (http:// announced that it has approved GlaxoSmithKline (GSK) company (http:// niraparib(name Zejula) extended indications for the treatment of patients with advanced ovaria
-
New crown inactivated vaccine to market as soon as this year or early next year
Time of Update: 2020-06-06
Medicine S June 1, according to the SASAC public number 29 news, as of now, the National Pharmaceutical Group China Biological Wuhan Biological Products Research Institute and Beijing Institute of B
-
GSK publishes full results from elantamab mafodotin (GSK2857916) treatment OfR/R MM critical clinical study
Time of Update: 2020-06-06
GlaxoSmithKline (GSK), the UK Pharmaceutical (http:// , recently announced that it has published an assessment of B-cell mature antigen (BCMA) targeted antibodies drug (http:// conjugal (ADC) b
-
Expert: Digital stethoscope technology can monitor early lung lesions
Time of Update: 2020-06-06
June 1st, World Health Organization data show that the global tobacco epidemic kills nearly 6 million people each year Experts say there is ample evidence that smoking is closely linked to diseases
-
Consistency evaluation research and development cost list: 47 drugs over 10 million Hengrui Pharmaceuticals accounted for 9
Time of Update: 2020-06-05
Medicine Network June 5, as of 2020/6/2, according to incomplete statistics of the pharmaceutical Rubik's Cube, listed companies have announced the research and development costs of the adoption of
-
2.2 billion star antifungal drug Qilu, Hengrui went to follow the original research 8 percent market danger
Time of Update: 2020-06-05
Pharmaceutical Network June 5th, June 4th, Qilu Pharmaceuticals to copy 4 categories of injection acetic acid carpofen net listing application to obtain CDE acceptance, acceptance number CYHS2000377
-
AstraZeneca Brinlinta approved by FDA for high-risk coronary artery disease patients
Time of Update: 2020-06-05
Pharmaceuticals,63 (AP) announced that the U.S Food and Drug Administration (FDA) has approved the anticoagulant brilinta (tecagrad) for use in patients with high-risk coronary artery disease (CAD)
-
Supplemental DHA does nothing to slow cognitive impairment in old age, u.S. study says
Time of Update: 2020-06-04
Business Agency, November 4th, many older people take fish oil health , because one of the main components of DHA is a very important component of the brain But a new U.S study says DHA does nunsa
-
Cook Medical Launches Abdominal Aortic Aneurysm Open Window Stent
Time of Update: 2020-06-04
Business Agency, May 11 (Xinhua) -- Cook Medical has launched Zenith Fenestrated, the world's first open window stent system for abdominal aortic aneurysm The stent system is designed for patients w
-
New portable blood detectors are cheap and accurate
Time of Update: 2020-06-04
research shows that a cheap, portable blood detector is as accurate as expensive hospital testing equipment in to detect diseases of love, syphilis and other infectious diseases researchers us
-
British study says more sensitive detection techniques could reduce heart disease deaths
Time of Update: 2020-06-04
28 (UPI) -- Using a new, more sensitive blood testing technique could detect more people at high risk of heart disease, which could significantly reduce heart disease deaths among potential patien
-
"Buzzy" New and Funny Child Injection Analgesic
Time of Update: 2020-06-04
Business Agency, May 11 - Health care workers and parents know that giving injections to children is a difficult task Because the vast majority of children are afraid of injections, they often cry a
-
Proteins found in the blood to accurately diagnose liver fibrosis
Time of Update: 2020-06-04
Business Agency, May 11by by the Beijing Proteomics Research Center He Fuchu and Qian Xiaohong researcherled the research team, using quantitative proteomics, the overall systematic discovery of 72
-
U.S. researchers find new source of heart stem cells
Time of Update: 2020-06-04
U.S researchers have discovered a stem cell in the outermost of heart that can produce heart muscle cells, it could play an important role in repairing damaged heart tissue a study publishe
-
Novartis releases Afinitor breast cancer BOLERO-2 secondary endpoint data
Time of Update: 2020-06-03
Business Agency, March 20 (Upi) -- Novartis released secondary endpoint data for the anti-cancer drug Afinitor Breast Cancer Phase III BOLERO-2 at the 9th European Breast Cancer Conference (EBCC-9)
-
Japan develops new drug to treat skin ulcers
Time of Update: 2020-06-03
Business Agency March 28 - The wound of the incurable skin ulcer has not healed for a long time, causing headaches Japanese researchers reported in the online edition of the U.S Public Library of S
-
Changchun high-tech new drug increases indications by drug clinical trial approval
Time of Update: 2020-06-03
Business Agency April 10, the evening of April 9, Changchun High-tech announcement, the company's holding subsidiary Changchun Jinsai Pharmaceutical Co., Ltd., polygycol recombinant human growth ho
-
AstraZeneca joins korea's KHIDI in virtual research and development of oncology drugs
Time of Update: 2020-06-03
Business, March 10 (Upi) -- AstraZeneca has dabbled in virtual model drug development, working with in-house teams and contractors around the world to make the process more efficient Now, following
-
New anti-lung cancer drug CM118 will enter clinical
Time of Update: 2020-06-03
Business Association March 6, Shanghai Re-New Pharmaceutical Technology Co., Ltd announced that the company's new anti-lung cancer drug CM118 project has completed preclinical research, and submitt
-
European Medicines Agency approves efficacy of inflammatory intestinal biologics
Time of Update: 2020-06-03
Business Agency, April 8 (Xinhua) -- The European Medicines Agency (EMA) Committee on Human Medicine products (CHMP) has a positive endorsement of Entyvio (vedolizumab), a biological agent it has s
